PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus ® in Type 1 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 1 Intervention: Drug: Gan & Lee Insulin Glargine Injection Sponsor: Gan and Lee Pharmaceuticals, USA Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | Insulin | Lantus | Research | Study